These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 13320759)

  • 21. [Antibiotics and the Sanarelli-Schwartzman phenomenon].
    DE CARO M
    Rend Ist Sup Sanit; 1952; 15(1):72-7. PubMed ID: 14920827
    [No Abstract]   [Full Text] [Related]  

  • 22. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
    KLOSA J
    Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mechanism of action of Shwartzman phenomenon. III. Effect of experimental neurosis on the course of Shwartzman phenomenon].
    KHUBETSOVA RD
    Biull Eksp Biol Med; 1955 Aug; 40(8):35-9. PubMed ID: 13276445
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sanarelli-Schwartzman phenomenon induced with chloramphenicol-resistant strains of S. typhi in vitro].
    CASSATA F; FONTI E
    Boll Soc Ital Biol Sper; 1952 Jan; 28(1):63-4. PubMed ID: 14944676
    [No Abstract]   [Full Text] [Related]  

  • 25. [Coagulatory and histomorphological modifications induced by 3-(1-phenyl-propyl)-4-hydroxycoumarin; experimental study].
    SALVI F
    Riv Anat Patol Oncol; 1954 May; 8(4):569-602. PubMed ID: 13225432
    [No Abstract]   [Full Text] [Related]  

  • 26. [Endotoxin hypersensitivity and relation of this phenomenon to the Shwartzman phenomenon].
    KOVATS TG; LAZAR G; VEGH P
    Kiserl Orvostud; 1962 Mar; 14():12-27. PubMed ID: 14459001
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of 3-(1-phenylpropyl)-4-hydroxycoumarin (marcumar) on the functional, morphological and histochemical characteristics of blood platelets and megakaryocytes; experimental research].
    SALVI F; RICCI M
    Haematologica; 1955; 39(6):425-40. PubMed ID: 13262650
    [No Abstract]   [Full Text] [Related]  

  • 28. [The possible tautomeric forms of 4-hydroxycoumarin].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 23(1):37-43. PubMed ID: 13066059
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the problem of blood coagulation disorder in the Sanarelli-Shwartzman phenomena (so-called generalized Shwartzman phenomenon) of the rabbit].
    KLEINMAIER H; GOERGEN K; LASCH HG; KRECKE HJ; BOHLE A
    Z Gesamte Exp Med; 1959; 132():275-94. PubMed ID: 14409739
    [No Abstract]   [Full Text] [Related]  

  • 30. [The Sanarelli-Shwartzman phenomenon and serum proteolytic activity].
    GHIRARDO G; GALLO G
    Pathologica; 1960; 52():17-20. PubMed ID: 13704933
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
    KNOBEL P
    Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
    [No Abstract]   [Full Text] [Related]  

  • 32. [Initial lesions of the Shwartzman phenomenon observed "in vivo"].
    LECOMTE J; HUGUES J; BETZ E; JOIRIS E
    Int Arch Allergy Appl Immunol; 1959; 15():237-44. PubMed ID: 14415090
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nervous system and immunity. VII. Effect of hypothermia on the Shwartzman phenomenon].
    CSERNYANSZKY H; KOCSAR L; SZILAGYI T
    Acta Microbiol Acad Sci Hung; 1956; 3(4):327-31. PubMed ID: 13354301
    [No Abstract]   [Full Text] [Related]  

  • 34. The secretion of 3,3'-ethylidene bis (4-hydroxycoumarin) in milk.
    FANTL P; NELSON JF
    Med J Aust; 1952 Mar; 1(12):404-5. PubMed ID: 14918772
    [No Abstract]   [Full Text] [Related]  

  • 35. The generalized Shwartzman phenomenon in rats.
    BRUNSON JG; GRONVALL JA
    AMA Arch Pathol; 1956 Oct; 62(4):324-34. PubMed ID: 13361676
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibacterial activity of compounds possessing a tricarbonylmethane group. X. Observations on the acetylation of 4-hydroxycoumarin and synthesis of 3-(alpha-aminophenylacetyl)-4-hydroxycoumarins].
    ARAKAWA K
    Pharm Bull; 1953 Dec; 1(4):331-4. PubMed ID: 13166555
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
    VERGANI G
    Gazz Med Ital; 1955 Dec; 114(12):269-73. PubMed ID: 13305779
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical significance of the Shwartzman phenomenon].
    REMPT F
    Ned Tijdschr Geneeskd; 1956 Feb; 100(7):471-5. PubMed ID: 13309485
    [No Abstract]   [Full Text] [Related]  

  • 39. [Glycoprotein changes in Shwartzman phenomenon].
    KOVATS TG; LAZAR G; REOK A; VEGH P
    Kiserl Orvostud; 1960 Feb; 12():30-4. PubMed ID: 14411454
    [No Abstract]   [Full Text] [Related]  

  • 40. Local endotoxin hypersensitivity and its relation to the Shwartzman phenomenon.
    KOVATS TG
    Nature; 1961 Apr; 190():177-8. PubMed ID: 13753682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.